Auf dieser Seite
CLDX Celldex Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026
$31,65
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$22,1052-Wochen-Tief
$45,1452-Wochen-Hoch
Marktkapitalisierung (MRQ)
$2.48B
P/E (TTM)
-7.3
EPS (TTM)
$-4.36
Umsatz (TTM)
$158.0K
Ihre Abzeichen
52W-Spanne
$22–$45
Analystenbewertung
BUY
Kursziel
$63
P/E
-7.3
ROE
-43.9%
Nettogewinnmarge
-190220.9%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
CLDX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$31.65
Marktkapitalisierung (MRQ)
$2.48B
P/E (TTM)
-7.3
EPS (TTM)
$-4.36
Umsatz (TTM)
$158.0K
ROE (TTM)
-43.9%
52W-Spanne
$22–$45
CLDX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 11. Februar 2019 | 1-for-15 | Umgekehrt |
| 10. März 2008 | 1-for-12 | Umgekehrt |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$2M2016-12-31 → 2025-12-31
EPS$-3.902019-12-31 → 2025-12-31
Freier Cashflow$-214M2016-12-31 → 2025-12-31
Nettogewinnmarge-190220.9%2025-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | CLDX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -7.35-Jahres-Durchschnitt ≈-14.6 | ≈-14.6 | · | · | |
| P/S (TTM) | 15724.95-Jahres-Durchschnitt ≈602.3 | ≈602.3 | 108.5 | Überbewertet | |
| K/B (MRQ) | 3.55-Jahres-Durchschnitt ≈4.3 | ≈4.3 | 4.4 | Fairer Wert | |
| Kurs / FCF (TTM) | -10.35-Jahres-Durchschnitt ≈-17.7 | ≈-17.7 | · | · | |
| Kurs / Cashflow (TTM) | -10.55-Jahres-Durchschnitt ≈-18.0 | ≈-18.0 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 3.65-Jahres-Durchschnitt ≈4.6 | ≈4.6 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | CLDX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -206220.9%5-Jahres-Durchschnitt ≈-6009.0% | ≈-6009.0% | -12208.9% | Schwach | |
| EBITDA-Marge (TTM) | -204071.5%5-Jahres-Durchschnitt ≈-5909.6% | ≈-5909.6% | -12208.9% | Schwach | |
| Pretax Margin (Vorgewinnmarge) | -16748.0%5-Jahres-Durchschnitt ≈-5467.6% | ≈-5467.6% | -525.2% | Schwach | |
| Nettogewinnmarge (TTM) | -190220.9% | · | -12108.9% | Schwach | |
| ROA (TTM) | -40.8% | · | -40.3% | Im Einklang | |
| ROE (TTM) | -43.9% | · | -50.3% | Im Einklang | |
| ROIC | -54.5% | · | -39.9% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | CLDX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 11.85-Jahres-Durchschnitt ≈17.0 | ≈17.0 | 14.8 | Geringe Liquidität | |
| Quick Ratio | 10.25-Jahres-Durchschnitt ≈16.6 | ≈16.6 | 13.0 | Im Einklang |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | CLDX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -78.0%5-Jahres-Durchschnitt ≈5.9% | ≈5.9% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -13.1%5-Jahres-Durchschnitt ≈-0.29% | ≈-0.29% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | -26.9% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | CLDX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.05-Jahres-Durchschnitt ≈0.0 | ≈0.0 | 0.0 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$7.8K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-3.3%
Nächster Bericht
Nov 09, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 6, 2026 | $-0.94 | $-1.08 | 12.8% |
| 31. März 2026 | $-1.18 | $-1.16 | -1.6% | |
| 31. Dezember 2025 | $-1.22 | $-1.03 | -18.6% | |
| 30. September 2025 | $-1.01 | $-0.92 | -9.9% | |
| 30. Juni 2025 | $-0.85 | $-0.87 | 2.6% | |
| 31. März 2025 | $-0.81 | $-0.77 | -5.2% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $7M | $7M | $2M | $5M | $7M | $4M | $10M | $13M | $7M | $5M | $4M | |
| Cost of Revenue | $200.0K | $200.0K | $300.0K | $100.0K | $100.0K | $200.0K | $100.0K | $700.0K | $700.0K | $2M | · | · | |
| R&D Expense | $245M | $164M | $118M | $82M | $53M | $43M | $43M | $66M | $96M | $103M | $100M | $104M | |
| SG&A Expense | $44M | $39M | $31M | $27M | $20M | $14M | $15M | $19M | $25M | $36M | $34M | $21M | |
| Operating Expenses | $289M | $202M | $161M | $118M | $76M | $71M | $59M | $166M | $134M | $140M | $135M | $126M | |
| Operating Income | $-287M | $-195M | $-155M | $-115M | $-71M | $-63M | $-55M | $-156M | $-122M | $-133M | $-130M | $-122M | |
| Pretax Income | $-259M | $-158M | $-141M | $-112M | $-71M | $-61M | $-51M | $-152M | $-117M | $-129M | $-127M | · | |
| Income Tax | $0 | $0 | $0 | · | $-227.0K | $-1M | · | $-765.0K | $-24M | · | · | · | |
| Net Income | $-259M | $-158M | $-141M | · | · | · | · | · | · | · | · | · | |
| EPS (Basic) | $-3.90 | $-2.45 | $-2.92 | $-2.40 | $-1.64 | $-2.02 | $-3.51 | · | · | · | · | · | |
| EPS (Diluted) | $-3.90 | $-2.45 | $-2.92 | $-2.40 | $-1.64 | $-2.02 | $-3.51 | · | · | · | · | · | |
| Shares (Basic) | 66,422,000 | 64,395,000 | 48,449,000 | 46,888 | 42,870 | 29,640 | 14,507 | · | · | · | · | · | |
| Shares (Diluted) | 66,422,000 | 64,395,000 | 48,449,000 | 46,888 | 42,870 | 29,640 | 14,507 | · | · | · | · | · | |
| EBITDA | $-284M | $-192M | $-152M | $-112M | $-68M | $-59M | $-50M | $-153M | $-117M | $-130M | $-127M | $-120M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $29M | $28M | $35M | $29M | $39M | $44M | $11M | $24M | $40M | $42M | $72M | $28M | |
| Short-term Investments | $490M | $697M | $389M | $276M | $369M | $151M | $53M | $70M | · | · | · | · | |
| Prepaid Expense | $14M | $21M | $5M | $12M | $2M | $2M | $1M | $2M | $3M | $4M | $4M | $4M | |
| Current Assets | $535M | $747M | $432M | $318M | $411M | $198M | $67M | $99M | $145M | $196M | $295M | $205M | |
| PP&E (Net) | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $6M | $10M | $13M | $11M | $11M | |
| PP&E (Gross) | $29M | $28M | $26M | $25M | $25M | $25M | $32M | $32M | $34M | $33M | $29M | $25M | |
| Accum. Depreciation | $24M | $23M | $22M | $22M | $21M | $21M | $28M | $26M | $24M | $20M | $17M | $14M | |
| Goodwill | · | · | · | · | · | · | · | · | $91M | $91M | $9M | $9M | |
| Intangibles | $27M | $27M | $27M | $27M | $27M | $31M | $49M | $49M | $68M | $81M | $21M | $22M | |
| Other Non-current Assets | $13M | $10M | $107.0K | $104.0K | $104.0K | $41.0K | $41.0K | $2M | $2M | $2M | $1M | $2M | |
| Total Assets | $583M | $792M | $466M | $353M | $445M | $236M | $123M | $156M | $316M | $383M | $338M | $248M | |
| Accounts Payable | $1M | $3M | $3M | $3M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $3M | |
| Accrued Liabilities | $47M | $34M | $22M | $13M | $12M | $8M | $6M | $7M | $19M | $29M | $24M | $19M | |
| Current Liabilities | $51M | $40M | $31M | $19M | $17M | $14M | $12M | $13M | $28M | $35M | $30M | $24M | |
| Capital Leases | $784.0K | $2M | $928.0K | $3M | $1M | $2M | $2M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $5M | $5M | |
| Other Non-current Liabilities | $4M | $3M | $4M | $5M | $7M | $10M | $16M | $19M | $52M | $83M | $17M | $12M | |
| Total Liabilities | $56M | $45M | $36M | $27M | $25M | $26M | $29M | $32M | $79M | $118M | $47M | $36M | |
| Common Stock | $67.0K | $66.0K | $56.0K | $47.0K | $47.0K | $40.0K | $17.0K | $12.0K | $9.0K | $121.0K | $99.0K | $90.0K | |
| Retained Earnings | $-1.81B | $-1.56B | $-1.40B | $-1.26B | $-1.14B | $-1.07B | $-1.01B | $-962M | $-813M | $-719M | $-591M | $-464M | |
| AOCI | $4M | $3M | $3M | $1M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | |
| Stockholders' Equity | $527M | $747M | $429M | $326M | $419M | $209M | $94M | $124M | $236M | $265M | $290M | $212M | |
| Liabilities + Equity | $583M | $792M | $466M | $353M | $445M | $236M | $123M | $156M | $316M | $383M | $338M | $248M | |
| Shares Outstanding | 66,549,442 | 66,374,549 | 55,883,377 | 47,200,695 | 46,730,198 | 39,603,771 | 16,972,077 | 11,957,635 | 9,234,693 | 120,516,654 | 98,685,595 | 89,592,779 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $3M | $3M | $3M | $4M | $5M | $4M | $4M | $3M | $3M | $2M | |
| Stock-based Comp | $36M | $34M | $24M | $16M | $9M | $4M | $5M | $8M | $12M | $15M | $13M | $7M | |
| Amort. of Intangibles | · | · | · | · | · | $0 | $0 | $224.0K | $896.0K | $997.0K | $1M | $1M | |
| Other Non-cash | $8M | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-211M | $-158M | $-107M | $-104M | $-61M | $-40M | $-46M | $-75M | $-100M | $-113M | $-99M | $-102M | |
| CapEx | $3M | $2M | $2M | $2M | $1M | $2M | $731.0K | $813.0K | $2M | $3M | $5M | $2M | |
| Investing Cash Flow | $209M | $-290M | $-106M | $90M | $-216M | $-98M | $17M | $30M | $46M | $69M | $-50M | · | |
| Stock Issued | · | $432M | $216M | · | $270M | $171M | $16M | $29M | $51M | $14M | $189M | · | |
| Net Stock Activity | · | $432M | $216M | · | $270M | $171M | $16M | $29M | $51M | $14M | $189M | · | |
| Financing Cash Flow | $2M | $441M | $218M | $4M | $272M | $171M | $16M | $29M | $51M | $14M | $193M | · | |
| Net Change in Cash | $515.0K | $-6M | $5M | $-10M | $-5M | $33M | $-13M | $-16M | $-2M | $-30M | $44M | $-141M | |
| Taxes Paid | $0 | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-214M | $-160M | $-109M | $-106M | $-62M | $-42M | $-47M | $-76M | $-102M | $-116M | $-104M | $-103M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -18599.8% | -2778.9% | -2245.3% | -4889.0% | -1531.8% | -854.1% | -1540.2% | · | -953.7% | -1958.7% | -2363.9% | -3414.1% | |
| Net Margin | -16748.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Pretax Margin | -16748.0% | -2248.8% | -2054.8% | -4765.6% | -1520.9% | -821.6% | -1424.0% | · | -920.6% | · | · | · | |
| EBITDA Margin | -18381.0% | -2733.6% | -2201.6% | -4766.1% | -1465.8% | -801.1% | -1404.2% | · | -919.0% | -1913.1% | -2309.2% | -3347.5% | |
| ROA | -37.6% | · | · | · | · | · | · | · | · | · | · | · | |
| ROE | -43.8% | · | · | · | · | · | · | · | · | · | · | · | |
| ROIC | -54.5% | · | · | · | -16.9% | -29.7% | · | -125.5% | -40.8% | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.5 | 18.9 | 13.9 | 17.1 | 24.9 | 13.9 | 5.7 | 7.9 | 5.2 | 5.6 | 9.8 | 8.4 | |
| Quick Ratio | 10.2 | 18.4 | 13.6 | 16.4 | 24.7 | 13.7 | 5.5 | 1.9 | 1.5 | 1.2 | 2.4 | 1.1 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.92 | $11.25 | $7.68 | $6.91 | $8.98 | $5.29 | $5.54 | $10.38 | $1.71 | $2.20 | $2.94 | $2.36 | |
| Revenue / Share | $0.02 | $109.01 | $142.07 | $50.27 | $108.49 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-3.18 | $-2450.16 | $-2214.51 | $-2212.34 | $-1420.78 | · | · | · | · | · | · | · | |
| Cash / Share | $0.43 | $0.43 | $0.62 | $0.62 | $0.84 | $1.11 | $0.66 | $2.03 | $0.29 | $0.35 | $0.73 | $0.31 | |
| EPS (TTM) | $-3.90 | $-2.45 | $-2.92 | $-2.40 | $-1.64 | $-2.02 | $-3.51 | · | · | · | · | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -78.0% | 2.0% | 192.0% | -49.3% | -37.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -13.1% | 14.7% | -2.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -26.9% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $7M | $7M | $2M | $5M | $7M | $4M | $10M | $13M | $7M | $5M | $4M | |
| Net Income TTM | $-259M | $-158M | $-141M | · | · | · | · | · | · | · | · | · | |
| Market Cap | $1.81B | $1.68B | $2.22B | $2.10B | $1.81B | $694M | $38M | $36M | $5.90B | $6.40B | $23.21B | $24.53B | |
| P/E | -7.0 | -10.3 | -13.6 | -18.6 | -23.6 | -8.7 | -0.6 | · | · | · | · | · | |
| P/S | 1169.9 | 238.9 | 322.0 | 892.5 | 388.2 | 93.5 | 10.6 | 3.8 | 463.1 | 943.0 | 4235.6 | 6839.4 | |
| P/B | 3.4 | 2.2 | 5.2 | 6.4 | 4.3 | 3.3 | 0.4 | 0.3 | 25.0 | 24.1 | 80.0 | 115.9 | |
| P / Tangible Book | 3.6 | 2.3 | 5.5 | 7.0 | 4.6 | 3.9 | · | · | · | · | · | · | |
| P / Cash Flow | -8.6 | -10.6 | -20.7 | -20.3 | -29.6 | -17.2 | -0.8 | -0.5 | -59.1 | -56.6 | -234.7 | -241.5 | |
| P / FCF | -8.5 | -10.5 | -20.3 | -19.9 | -29.0 | -16.5 | -0.8 | -0.5 | -58.0 | -55.3 | -223.7 | -237.0 | |
| Earnings Yield | -14.4% | -9.7% | -7.4% | -5.4% | -4.2% | -11.5% | -157.4% | · | · | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $22.0K | $15.0K | $121.0K | $0 | $730.0K | $695.0K | $1M | $3M | $2M | $156.0K | $2M | $268.0K | $967.0K | $407.0K | $163.0K | $174.0K | |
| R&D Expense | $68M | $73M | $75M | $63M | $54M | $53M | $47M | $45M | $40M | $32M | $35M | $26M | $27M | $22M | $21M | $17M | |
| SG&A Expense | $13M | $11M | $12M | $11M | $10M | $11M | $10M | $10M | $9M | $9M | $8M | $7M | $7M | $7M | $7M | $7M | |
| Operating Expenses | $81M | $84M | $87M | $74M | $65M | $63M | $57M | $55M | $49M | $41M | $43M | $33M | $33M | $28M | $37M | $23M | |
| Operating Income | $-81M | $-84M | $-87M | $-74M | $-64M | $-63M | $-56M | $-52M | $-46M | $-41M | $-41M | $-33M | $-32M | $-28M | $-36M | $-23M | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | · | · | · | $-27M | $-36M | $-23M | |
| Net Income | $-74M | $-79M | $-81M | $-67M | $-57M | $-54M | $-47M | $-42M | $-36M | $-33M | · | · | · | · | · | · | |
| EPS (Basic) | $-0.94 | $-1.18 | $-1.23 | $-1.01 | $-0.85 | $-0.81 | $-0.71 | $-0.64 | $-0.54 | $-0.56 | $-0.81 | $-0.65 | $-0.62 | $-0.57 | $-0.77 | $-0.49 | |
| EPS (Diluted) | $-0.94 | $-1.18 | $-1.23 | $-1.01 | $-0.85 | $-0.81 | $-0.71 | $-0.64 | $-0.54 | $-0.56 | $-0.81 | $-0.65 | $-0.62 | $-0.57 | $-0.77 | $-0.49 | |
| Shares (Basic) | 77,840,000 | 66,566,000 | · | 66,420 | 66,392,000 | 66,383,000 | · | 66,294 | 66,019 | 58,871 | 47,261 | 47,253 | 47,214 | 46,916 | 46,759 | 46,739 | |
| Shares (Diluted) | 77,840,000 | 66,566,000 | · | 66,420 | 66,392,000 | 66,383,000 | · | 66,294 | 66,019 | 58,871 | 47,261 | 47,253 | 47,214 | 46,916 | 46,759 | 46,739 | |
| EBITDA | $-81M | · | · | $-74M | $-64M | $-62M | · | $-52M | $-46M | $-40M | $-41M | $-33M | $-32M | $-28M | $-36M | $-22M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $47M | $36M | $29M | $36M | $23M | $17M | $28M | $36M | $43M | $115M | $21M | $28M | $54M | $19M | $28M | $25M | |
| Short-term Investments | $670M | $416M | $490M | $547M | $607M | $656M | $697M | $720M | $760M | $709M | $214M | $224M | $224M | $305M | $328M | $355M | |
| Prepaid Expense | $7M | $8M | $14M | $21M | $18M | $19M | $21M | $22M | $8M | $9M | $10M | $12M | $10M | $11M | $11M | $10M | |
| Current Assets | $725M | $459M | $535M | $604M | $648M | $694M | $747M | $779M | $812M | $835M | $246M | $265M | $290M | $335M | $368M | $391M | |
| PP&E (Net) | $10M | $7M | $5M | $5M | $4M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | |
| PP&E (Gross) | · | · | $29M | · | · | · | $28M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $24M | · | · | · | $23M | · | · | · | · | · | · | · | · | · | |
| Intangibles | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | |
| Other Non-current Assets | $15M | $15M | $13M | $9M | $9M | $10M | $10M | $10M | $107.0K | $107.0K | $107.0K | $107.0K | $104.0K | $104.0K | $104.0K | $104.0K | |
| Total Assets | $782M | $511M | $583M | $648M | $692M | $739M | $792M | $823M | $846M | $869M | $280M | $299M | $325M | $369M | $403M | $424M | |
| Accounts Payable | $15M | $10M | $1M | $4M | $2M | $3M | $3M | $1M | $4M | $3M | $4M | $881.0K | $3M | $2M | $902.0K | $1M | |
| Accrued Liabilities | $44M | $38M | $47M | $40M | $28M | $25M | $34M | $28M | $19M | $18M | $18M | $12M | $9M | $11M | $11M | $9M | |
| Current Liabilities | $61M | $51M | $51M | $46M | $33M | $32M | $40M | $32M | $28M | $26M | $28M | $16M | $15M | $16M | $30M | $15M | |
| Capital Leases | $3M | $443.0K | $784.0K | $1M | $1M | $2M | $2M | $2M | $796.0K | $470.0K | $1M | $2M | $2M | $2M | $3M | $841.0K | |
| Other Non-current Liabilities | $3M | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | $11M | |
| Total Liabilities | $68M | $55M | $56M | $50M | $37M | $36M | $45M | $37M | $32M | $30M | $34M | $22M | $22M | $24M | $38M | $26M | |
| Common Stock | $79.0K | $67.0K | $67.0K | $66.0K | $66.0K | $66.0K | $66.0K | $66.0K | $66.0K | $66.0K | $47.0K | $47.0K | $47.0K | $47.0K | $47.0K | $47.0K | |
| Retained Earnings | $-1.97B | $-1.89B | $-1.81B | $-1.73B | $-1.67B | $-1.61B | $-1.56B | $-1.51B | $-1.47B | $-1.43B | $-1.35B | $-1.32B | $-1.29B | $-1.23B | $-1.20B | $-1.17B | |
| AOCI | $1M | $3M | $4M | $4M | $3M | $4M | $3M | $5M | $2M | $2M | $2M | $2M | $2M | $-112.0K | $-417.0K | $112.0K | |
| Stockholders' Equity | $715M | $456M | $527M | $598M | $655M | $703M | $747M | $786M | $814M | $839M | $247M | $278M | $303M | $345M | $365M | $398M | |
| Liabilities + Equity | $782M | $511M | $583M | $648M | $692M | $739M | $792M | $823M | $846M | $869M | $280M | $299M | $325M | $369M | $403M | $424M | |
| Shares Outstanding | 78,500,173 | 66,568,971 | 66,549,442 | 66,446,846 | 66,394,241 | 66,384,191 | 66,374,549 | 66,344,236 | 66,280,667 | 65,910,548 | 47,264,197 | 47,253,813 | 47,244,681 | 47,096,063 | 46,764,703 | 46,754,348 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $902.0K | $854.0K | $816.0K | $824.0K | $873.0K | $867.0K | $819.0K | $786.0K | $797.0K | $775.0K | $767.0K | $756.0K | $726.0K | $671.0K | $741.0K | $811.0K | |
| Stock-based Comp | $8M | $9M | $9M | $9M | $9M | $9M | $10M | $10M | $8M | $7M | $7M | $5M | $4M | $4M | $3M | $3M | |
| Operating Cash Flow | $-57M | $-66M | $-64M | $-49M | $-44M | $-54M | $-32M | $-55M | $-29M | $-41M | $-19M | $-27M | $-29M | $-35M | $-22M | $-25M | |
| CapEx | $3M | $2M | $1M | $440.0K | $728.0K | $265.0K | $756.0K | $545.0K | $274.0K | $344.0K | $157.0K | $410.0K | $585.0K | $345.0K | $673.0K | $575.0K | |
| Investing Cash Flow | $-256M | $72M | $55M | $61M | $50M | $43M | $24M | $48M | $-47M | $-315M | $12M | $1M | $53M | $23M | $25M | $10M | |
| Stock Issued | · | · | · | · | · | · | $0 | $0 | $0 | $432M | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $432M | · | · | · | · | · | · | |
| Financing Cash Flow | $325M | $327.0K | $1M | $774.0K | $63.0K | $202.0K | $386.0K | $1M | $4M | $436M | $257.0K | $133.0K | $694.0K | $2M | $71.0K | $304.0K | |
| Net Change in Cash | $12M | $7M | $-7M | $13M | $6M | $-11M | $-8M | $-6M | $-72M | $80M | $-7M | $-26M | $25M | $-10M | $3M | $-14M | |
| Free Cash Flow | · | · | · | · | · | $-55M | · | · | · | $-41M | · | · | $-29M | · | · | $-25M |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -366468.2% | · | · | · | -8747.5% | -9027.2% | · | -1633.5% | -1854.2% | -26030.8% | -2718.5% | -12389.9% | -3357.9% | -6804.9% | -22328.8% | -13366.1% | |
| Net Margin | -334104.6% | · | · | · | -7753.4% | · | · | · | · | · | · | · | · | · | · | · | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | -6580.8% | -22088.3% | -13247.1% | |
| EBITDA Margin | -366468.2% | · | · | · | -8747.5% | -8902.5% | · | -1633.5% | -1854.2% | -25534.0% | -2718.5% | -12389.9% | -3282.8% | -6804.9% | -22328.8% | -12900.0% | |
| ROA | -10.0% | · | · | -9.1% | -7.4% | · | · | · | · | · | · | · | · | · | · | · | |
| ROE | -10.7% | · | · | -9.7% | -7.7% | · | · | · | · | · | · | · | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.8 | · | · | 13.0 | 19.7 | 21.7 | · | 24.3 | 29.4 | 31.8 | 8.8 | 16.9 | 19.0 | 20.5 | 12.3 | 26.8 | |
| Quick Ratio | 11.7 | · | · | 12.6 | 19.1 | 21.0 | · | 23.6 | 29.0 | 31.3 | 8.5 | 16.2 | 18.3 | 19.9 | 11.9 | 26.1 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $9.10 | · | · | $9.01 | $9.87 | $10.59 | · | $11.85 | $12.28 | $12.72 | $5.22 | $5.87 | $6.41 | $7.33 | $7.81 | $8.51 | |
| Revenue / Share | $0.00 | · | · | · | $11.00 | $10.47 | · | $48.13 | $37.84 | $2.65 | $32.10 | $5.67 | $20.48 | $0.01 | $0.00 | $0.00 | |
| Cash Flow / Share | · | · | · | · | · | $-819.07 | · | · | · | $-690.29 | · | · | $-605.10 | · | · | $-0.52 | |
| Cash / Share | $0.60 | · | · | $0.54 | $0.35 | $0.26 | · | $0.55 | $0.64 | $1.75 | $0.45 | $0.60 | $1.15 | $0.39 | $0.61 | $0.54 | |
| EPS (TTM) | $-4.36 | $-3.85 | · | $-3.38 | $-3.01 | $-2.70 | · | $-2.58 | $-2.75 | $-2.86 | $-2.65 | $-2.41 | $-2.53 | $-2.26 | $-2.14 | $-1.71 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $158.0K | · | · | $3M | $6M | $8M | · | $10M | $8M | $6M | $4M | $3M | $3M | $1M | $823.0K | $4M | |
| Net Income TTM | $-301M | $-256M | · | $-225M | $-200M | $-179M | · | · | · | · | · | · | · | · | · | · | |
| Market Cap | $2.92B | · | · | $1.72B | $1.35B | $1.20B | · | $2.26B | $2.45B | $2.77B | $1.30B | $1.60B | $1.70B | $1.32B | $1.26B | $1.59B | |
| P/E | -8.5 | -8.2 | · | -7.7 | -6.8 | -6.7 | · | -13.2 | -13.5 | -14.7 | -10.4 | -14.1 | -14.2 | -12.4 | -12.6 | -19.9 | |
| P/S | 18487.3 | · | · | 661.1 | 233.3 | 159.4 | · | 226.0 | 295.5 | 455.6 | 298.0 | 492.6 | 539.6 | 1229.2 | 1531.9 | 384.7 | |
| P/B | 4.1 | · | · | 2.9 | 2.1 | 1.7 | · | 2.9 | 3.0 | 3.3 | 5.3 | 5.8 | 5.6 | 3.8 | 3.5 | 4.0 | |
| P / Tangible Book | 4.2 | 4.9 | · | 3.0 | 2.2 | 1.8 | · | 3.0 | 3.1 | 3.4 | 5.9 | 6.4 | 6.2 | 4.2 | 3.7 | 4.3 | |
| P / Cash Flow | · | · | · | · | · | -22.2 | · | · | · | -68.1 | · | · | -59.5 | · | · | -64.9 | |
| Earnings Yield | -11.7% | -12.1% | · | -13.1% | -14.8% | -14.9% | · | -7.6% | -7.4% | -6.8% | -9.6% | -7.1% | -7.0% | -8.0% | -7.9% | -5.0% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $2M | $7M | $7M | $2M | $5M |
| Betriebsgewinnmarge % | -18599.8% | -2778.9% | -2245.3% | -4889.0% | -1531.8% |
| Nettoergebnis | $-259M | $-158M | $-141M | · | · |
| Verwässerte EPS | $-3.90 | $-2.45 | $-2.92 | $-2.40 | $-1.64 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 10.5 | 18.9 | 13.9 | 17.1 | 24.9 |
| Quick Ratio | 10.2 | 18.4 | 13.6 | 16.4 | 24.7 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-214M | $-160M | $-109M | $-106M | $-62M |
Institutionelle Eigentümer (13F) 276 Einreicher · $3.1B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
276
Gehaltener Wert
$3.1B
Neue Positionen
55
Geschlossene Positionen
20
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 55 (-12 vs. Vorquartal) | 20 (+8 vs. Vorquartal) | 106 (+39 vs. Vorquartal) | 58 (0 vs. Vorquartal) | +12.5M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | $355.119.999 | 9.543.671 | 11,38% | Aktien |
| BlackRock, Inc. | $260.564.141 | 7.002.530 | 8,35% | Aktien |
| Kynam Capital Management, LP | $198.065.407 | 5.322.908 | 6,35% | Aktien |
| STATE STREET CORP | $145.134.889 | 3.900.427 | 4,65% | Aktien |
| FMR LLC | $138.528.663 | 3.722.888 | 4,44% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $128.926.362 | 3.464.831 | 4,13% | Aktien |
| VANGUARD GROUP INC | $109.384.374 | 4.027.407 | 3,50% | Aktien |
| Deep Track Capital, LP | $109.365.809 | 2.939.151 | 3,50% | Aktien |
| Logos Global Management LP | $78.141.000 | 2.100.000 | 2,50% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $75.262.712 | 2.022.226 | 2,41% | Aktien |
| Eversept Partners, LP | $66.454.865 | 1.785.941 | 2,13% | Aktien |
| GOLDMAN SACHS GROUP INC | $60.106.913 | 1.615.343 | 1,93% | Aktien |
| Commodore Capital LP | $50.233.500 | 1.350.000 | 1,61% | Aktien |
| Bellevue Group AG | $44.652.000 | 1.200.000 | 1,43% | Aktien |
| BAKER BROS. ADVISORS LP | $44.004.955 | 1.182.611 | 1,41% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $43.564.984 | 1.170.787 | 1,40% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $39.964.295 | 1.073.985 | 1,28% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $38.787.594 | 1.042.395 | 1,24% | Aktien |
| EVENTIDE ASSET MANAGEMENT, LLC | $38.586.770 | 1.037.000 | 1,24% | Aktien |
| NOVO HOLDINGS A/S | $38.140.250 | 1.025.000 | 1,22% | Aktien |
| Elmind Capital, LP | $36.837.900 | 990.000 | 1,18% | Aktien |
| Driehaus Capital Management LLC | $36.817.137 | 989.442 | 1,18% | Aktien |
| Fisher Asset Management, LLC | $36.677.040 | 985.677 | 1,17% | Aktien |
| Pictet Asset Management Holding SA | $34.136.752 | 917.408 | 1,09% | Aktien |
| Foresite Capital Management VI LLC | $32.734.121 | 879.713 | 1,05% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $32.132.175 | 863.536 | 1,03% | Aktien |
| Assenagon Asset Management S.A. | $29.347.378 | 788.696 | 0,94% | Aktien |
| NORTHERN TRUST CORP | $26.778.065 | 719.647 | 0,86% | Aktien |
| Woodline Partners LP | $26.077.884 | 700.830 | 0,84% | Aktien |
| Affinity Asset Advisors, LLC | $26.047.000 | 700.000 | 0,83% | Aktien |
| Rock Springs Capital Management LP | $26.015.223 | 699.146 | 0,83% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $24.604.554 | 661.235 | 0,79% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $24.408.048 | 655.954 | 0,78% | Aktien |
| ALGERT GLOBAL LLC | $24.105.978 | 647.836 | 0,77% | Aktien |
| ADAR1 Capital Management, LLC | $23.053.158 | 619.542 | 0,74% | Aktien |
| BANK OF AMERICA CORP /DE/ | $22.593.726 | 607.195 | 0,72% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $21.304.139 | 572.538 | 0,68% | Aktien |
| Nuveen, LLC | $21.152.396 | 568.460 | 0,68% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $20.576.125 | 552.973 | 0,66% | Aktien |
| 5AM Venture Management, LLC | $18.503.417 | 497.270 | 0,59% | Aktien |
| FEDERATED HERMES, INC. | $18.340.549 | 492.893 | 0,59% | Aktien |
| UBS Group AG | $17.935.109 | 481.997 | 0,57% | Aktien |
| Candriam S.C.A. | $17.885.437 | 481.125 | 0,57% | Aktien |
| Ikarian Capital, LLC | $17.804.985 | 478.500 | 0,57% | Aktien |
| BRAIDWELL LP | $16.247.598 | 436.646 | 0,52% | Aktien |
| Redmile Group, LLC | $16.146.200 | 433.921 | 0,52% | Aktien |
| CITIGROUP INC | $15.058.998 | 404.703 | 0,48% | Aktien |
| Palo Alto Investors LP | $14.878.642 | 399.856 | 0,48% | Aktien |
| TSP Capital Management Group, LLC | $13.809.638 | 371.127 | 0,44% | Aktien |
| PFM Health Sciences, LP | $12.753.765 | 342.751 | 0,41% | Aktien |
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Medarex, Inc. I.R.S. Employer Identification Number ×3 Einreichungen | 26. Juni 2009 | · | Erste Einreichung | · | SEC |
| Lorantis Holdings Limited ×2 Einreichungen | 12. Mai 2008 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 49 Insider · 18 Führungskräfte · 23 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Anthony S Marucci | PRESIDENT & CEO | 25. Juni 2026 A | 40.284 | 0 | 0 | $0 |
| Una S Ryan | President & CEO | 7. März 2008 A | 899.213 | 0 | 0 | $0 |
| Samuel Bates Martin | SVP AND CFO | 25. Juni 2026 A | 32.942 | 0 | 0 | $0 |
| Avery W Catlin | Sr. VP & CFO | 2. September 2016 M | 83.586 | 0 | 0 | $0 |
| Teri L Lawver | SVP & Chief Commercial Officer | 25. Juni 2026 A | · | 0 | 0 | $0 |
| Freddy A. Jimenez | SVP & GENERAL COUNSEL | 25. Juni 2026 A | 30.796 | 0 | 1 | $-121.231 |
| Margo Heath-Chiozzi | SVP OF REGULATORY AFFAIRS | 25. Juni 2026 A | 13.383 | 0 | 0 | $0 |
| Sarah Cavanaugh | SVP OF CORP AFFAIRS & ADMIN. | 25. Juni 2026 A | 1.860 | 0 | 0 | $0 |
| Elizabeth Crowley | SR. VP & CPDO | 25. Juni 2026 A | 9.074 | 0 | 0 | $0 |
| Diane C. Young | SVP, CHIEF MEDICAL OFFICER | 25. Juni 2026 A | 17.115 | 0 | 0 | $0 |
| Tibor Keler | EXECUTIVE VP & CSO | 25. Juni 2026 A | 7.357 | 0 | 0 | $0 |
| Ronald Pepin | SR. VP & CBO | 25. Juni 2026 A | 20.097 | 0 | 0 | $0 |
| Theresa Lavallee | SVP, Reg.& Precision Medicine | 14. Dezember 2016 A | · | 0 | 0 | $0 |
| Ronald C Newbold | Sr. VP, Business Dev. | 6. Januar 2009 A | 5.868 | 0 | 0 | $0 |
| Henry C Marsh JR | V.P. Research | 7. März 2008 M | · | 0 | 0 | $0 |
| Ronald W Ellis | Sr VP R&D | 5. Januar 2007 A | · | 0 | 0 | $0 |
| Michael E Furlong | Sr. Dir. Bus. Development | 1. Juli 2005 L | 1.500 | 0 | 0 | $0 |
| Alistair Wheeler | V.P. Medical Affairs | 2. Januar 2004 A | · | 0 | 0 | $0 |
| Denice Torres | Direktor | 25. Juni 2026 A | · | 0 | 0 | $0 |
| Rita Jain | Direktor | 25. Juni 2026 A | · | 0 | 0 | $0 |
| Garry Arthur Neil | Direktor | 25. Juni 2026 A | · | 0 | 0 | $0 |
| Cheryl Cohen | Direktor | 25. Juni 2026 A | · | 0 | 0 | $0 |
| Keith L Brownlie | Direktor | 25. Juni 2026 A | 10.000 | 0 | 0 | $0 |
| Herbert J Conrad | Direktor | 25. Juni 2026 A | 38.500 | 0 | 0 | $0 |
| James J Marino | Direktor | 25. Juni 2026 A | 2.204 | 0 | 0 | $0 |
| Harry Penner JR | Direktor | 25. Juni 2026 A | 41.916 | 0 | 0 | $0 |
| Karen Shoos Lipton | Direktor | 13. Juni 2024 A | 41.833 | 0 | 0 | $0 |
| Gerald Mcmahon PhD | Direktor | 3. Dezember 2018 F | 180.697 | 0 | 0 | $0 |
| Larry Ellberger | Direktor | 13. Juni 2018 A | 73.500 | 0 | 0 | $0 |
| Richard Van Den Broek | Direktor | 8. Juni 2016 A | 233.500 | 0 | 0 | $0 |
| Timothy M Shannon | Direktor | 4. Juni 2014 A | 83.212 | 0 | 0 | $0 |
| Rajesh R Parekh | Direktor | 22. September 2010 A | 2.000 | 0 | 0 | $0 |
| Charles R Schaller | Direktor | 9. September 2010 P | 5.000 | 0 | 0 | $0 |
| Alf A Lindberg | Direktor | 24. Mai 2007 A | · | 0 | 0 | $0 |
| Francis R Cano | Direktor | 24. Mai 2007 A | · | 0 | 0 | $0 |
| Peter A Sears | Direktor | 24. Mai 2007 A | 72.739 | 0 | 0 | $0 |
| Barrie J Ward | Direktor | 25. Mai 2006 A | 367.915 | 0 | 0 | $0 |
| PDI INC | Direktor | 26. Mai 2005 A | · | 0 | 0 | $0 |
| Frederick W Kyle | Direktor | 13. Mai 2004 C | 7.000 | 0 | 0 | $0 |
| MEDAREX INC | 10%-Eigentümer | 24. Juni 2009 S | 2.960.848 | 0 | 0 | $0 |
| Lorantis Holdings LTD | 10%-Eigentümer | 7. April 2008 J | 0 | 0 | 0 | $0 |
| Richard M. Wright | · | 13. November 2025 M | 20.833 | 0 | 1 | $-1.183.152 |
| Thomas Andrew Davis | · | 15. Juni 2017 A | 1.011 | 0 | 0 | $0 |
| George Elston | · | 8. Juni 2016 A | 28.500 | 0 | 0 | $0 |
| Taha Keilani | · | 7. März 2008 A | 2.000 | 0 | 0 | $0 |
| Paula R Freeman | · | 7. März 2008 M | 2.955 | 0 | 0 | $0 |
| Michael Timothy Cooke | · | 5. Januar 2007 A | · | 0 | 0 | $0 |
| Mary Nicholson | · | 3. Januar 2005 A | 500 | 0 | 0 | $0 |
| Anthony Helstosky | · | 6. Januar 2004 C | 6.000 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 37 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,82% | 9.940 NS | 31. Juli 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,53% | 68.644 NS | 31. Juli 2026 | N-PORT |
| IWO · iShares Trust | 0,16% | 594.426 SH | 11. September 2026 | Täglich |
| FFSM · FIDELITY COVINGTON TRUST | 0,15% | 58.481 NS | 31. Juli 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,15% | 938 NS | 31. Juli 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,14% | 67.853 SH | 19. August 2026 | Täglich |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,14% | 46.273 NS | 31. Juli 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,10% | 8.061 SH | 2. Oktober 2026 | Täglich |
| IWM · iShares Trust | 0,10% | 2.001.452 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,10% | 37.420 NS | 31. Juli 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,10% | 17.472 NS | 31. Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,09% | 449.534 SH | 19. August 2026 | Täglich |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,07% | 23.443 NS | 31. Juli 2026 | N-PORT |
| ESML · iShares Trust | 0,06% | 44.331 SH | 11. September 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,06% | 48.207 SH | 2. Oktober 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,05% | 202.557 NS | 31. Juli 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,04% | 12.901 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,04% | 201.834 SH | 19. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,04% | 31.885 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 897.276 SH | 19. August 2026 | Täglich |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,03% | 4.194 NS | 31. Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,03% | 4.663 SH | 11. September 2026 | Täglich |
| DCOR · Dimensional ETF Trust | 0,01% | 7.780 NS | 31. Juli 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 4.860 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 79.126 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 15.559 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 117.257 SH | 11. September 2026 | Täglich |
| DFSU · Dimensional ETF Trust | 0,00% | 2.758 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 22.607 SH | 9. September 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,00% | 414 NS | 31. Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 10.101 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.488.906 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6.489 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 137.538 SH | 11. September 2026 | Täglich |
| ISCB · iShares Trust | · | 2.846 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 14.142 SH | 11. September 2026 | Täglich |
| SMMV · iShares Trust | · | 6.524 SH | 19. August 2026 | Täglich |
CLDX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 22 Analysten
KAUF
Median-Ziel
$64.00
+102,2%
7 31,8%
Starker Kauf
13 59,1%
Kauf
2 9,1%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
14 Analysten · 2026-10-02Mittelwert-Ziel $63.07 +99,3%
Jetzt
Aktueller Preis $31.65
Tief$28.00
Mittelwert$63.07
Hoch$100.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| CLDX | $1.81B | -7.0 | -78.0% | -16748.0% | -43.8% | · |
| PGEN | $1.48B | -3.1 | 146.7% | -2588.2% | 3159.1% | · |
| DYN | $3.23B | -5.6 | · | · | -57.8% | · |
| PURR | $1.58B | 2.5 | · | 3229.8% | 24.8% | · |
| BEAM | $2.82B | -34.2 | 120.0% | -57.2% | -7.0% | · |
| IRON | $3.01B | -13.2 | · | · | -31.3% | · |
| NRIX | $1.80B | -5.8 | 53.9% | -314.9% | -53.6% | · |
| SLS | $577M | -15.1 | · | · | -55.4% | · |
| IMNM | $2.43B | -8.8 | -23.2% | -3060.0% | -47.0% | · |
| VRDN | $3.17B | -7.7 | 23359.9% | -483.6% | -55.4% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026